NCT03880396View on ClinicalTrials.gov

Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

March 10, 2019

Primary Completion Date

December 26, 2020

Study Completion Date

December 26, 2020

Conditions
Squamous Cell Carcinoma of the Head and Neck
Interventions
RADIATION

hypofractionated Rth with platinol

hypofractionated Rth with weekly cisplatin 40mg/m2

Trial Locations (1)

+2

Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03880396 - Definitive Concurrent Hypofractionated Rth With Weekly Cisplatin in Locally Advanced SCCHN | Biotech Hunter | Biotech Hunter